Minerva Neurosciences (NERV) Short Interest Ratio & Short Volume → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free NERV Stock Alerts $2.52 -0.05 (-1.95%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Minerva Neurosciences Short Interest DataCurrent Short Volume25,500 sharesPrevious Short Volume30,500 sharesChange Vs. Previous Month-16.39%Dollar Volume Sold Short$60,177.45Short Interest Ratio / Days to Cover0.2Last Record DateApril 30, 2024Outstanding Shares6,990,000 sharesFloat Size5,440,000 sharesShort Percent of Float0.47%Today's Trading Volume2,100 sharesAverage Trading Volume86,278 sharesToday's Volume Vs. Average2% Short Selling Minerva Neurosciences ? Sign up to receive the latest short interest report for Minerva Neurosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNERV Short Interest Over TimeNERV Days to Cover Over TimeNERV Percentage of Float Shorted Over Time Ad Stansberry Research41 banks launch ‘crypto dollar’Everyone knows the US financial system is in the middle of a radical change... The White House wants an all-digital dollar. Plus at least 41 major banks (see if your bank is one of them right here).Here's how you capitalize (including #1 crypto to play it). Minerva Neurosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202425,500 shares $60,177.45 -16.4%0.5%0.2 $2.36 4/15/202430,500 shares $73,810.00 -24.3%0.6%0.3 $2.42 3/31/202440,300 shares $103,974.00 +5.2%0.7%0.3 $2.58 3/15/202438,300 shares $106,857.00 -68.7%0.7%0.3 $2.79 2/29/2024122,400 shares $326,808.00 +416.5%2.3%1.1 $2.67 2/15/202423,700 shares $222,780.00 +25.4%0.5%0.3 $9.40 Get the Latest News and Ratings for NERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/202418,900 shares $159,705.00 +33.1%0.4%0.5 $8.45 1/15/202414,200 shares $105,790.00 -55.6%0.3%0.5 $7.45 12/31/202332,000 shares $196,800.00 -30.6%0.7%1.3 $6.15 12/15/202346,100 shares $297,345.00 -37.4%1.0%2.3 $6.45 11/30/202373,600 shares $577,760.00 -6.5%1.5%3.6 $7.85 11/15/202378,700 shares $408,453.00 +53.7%1.6%4.2 $5.19 10/31/202351,200 shares $246,784.00 +4.5%1.1%2.4 $4.82 10/15/202349,000 shares $279,790.00 -17.0%1.0%1.8 $5.71 9/30/202359,000 shares $407,100.00 -20.3%1.2%1.3 $6.90 9/15/202374,000 shares $575,720.00 -7.9%1.5%0.1 $7.78 8/31/202380,300 shares $672,111.00 -21.1%1.9%0.1 $8.37 8/15/2023101,800 shares $911,110.00 -17.0%2.4%0.1 $8.95 7/31/2023122,700 shares $1.17 million +16.6%2.9%0.1 $9.51 7/15/2023105,200 shares $1.27 million -75.8%3.1%0.1 $12.07 6/30/2023434,000 shares $3.97 million +540.1%12.8%0.4 $9.14 6/15/202367,800 shares $496,296.00 -49.8%1.5%0.3 $7.32 5/31/2023135,000 shares $805,950.00 -54.6%2.9%0.7 $5.97 5/15/2023297,300 shares $1.91 million +263.5%6.4%1.6 $6.44 4/30/202381,800 shares $229,040.00 -22.7%1.8%0.5 $2.80 4/15/2023105,800 shares $241,224.00 +27.2%2.3%1.7 $2.28 3/31/202383,200 shares $133,120.00 -8.0%1.8%1.1 $1.60 3/15/202390,400 shares $157,296.00 -20.1%2.0%1 $1.74 2/28/2023113,200 shares $244,512.00 +15.9%2.5%1.2 $2.16 2/15/202397,700 shares $230,572.00 -4.0%2.2%1 $2.36 1/31/2023101,800 shares $243,302.00 -41.5%2.2%0.6 $2.39 1/15/2023174,100 shares $386,502.00 +20.2%3.8%1 $2.22 12/30/2022144,900 shares $230,391.00 -26.6%3.2%0.5 $1.59 12/15/2022197,300 shares $554,413.00 -21.5%4.3%0.6 $2.81 11/30/2022251,300 shares $889,602.00 +0.8%5.5%0.6 $3.54 11/15/2022249,200 shares $859,740.00 +79.3%5.5%0.1 $3.45 10/31/2022139,000 shares $368,350.00 -57.2%3.1%0 $2.65 10/15/2022324,600 shares $4.36 million -43.4%7.1%0.1 $13.43 9/30/2022573,400 shares $5.29 million -47.4%12.6%0.1 $9.23 9/15/20221,090,000 shares $9.88 million -31.9%24.0%0.2 $9.06Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… NERV Short Interest - Frequently Asked Questions What is Minerva Neurosciences' current short interest? Short interest is the volume of Minerva Neurosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 25,500 shares of NERV short. 0.47% of Minerva Neurosciences' shares are currently sold short. Learn More on Minerva Neurosciences' current short interest. What is a good short interest percentage for Minerva Neurosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.47% of Minerva Neurosciences' floating shares are currently sold short. Is Minerva Neurosciences' short interest increasing or decreasing? Minerva Neurosciences saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 25,500 shares, a decline of 16.4% from the previous total of 30,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Minerva Neurosciences' float size? Minerva Neurosciences currently has issued a total of 6,990,000 shares. Some of Minerva Neurosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Minerva Neurosciences currently has a public float of 5,440,000 shares. How does Minerva Neurosciences' short interest compare to its competitors? 0.47% of Minerva Neurosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Minerva Neurosciences: Talphera, Inc. (0.90%), GlycoMimetics, Inc. (9.45%), Flora Growth Corp. (1.40%), VBI Vaccines Inc. (1.38%), Vincerx Pharma, Inc. (5.98%), Galecto, Inc. (0.42%), Aytu BioPharma, Inc. (7.15%), Sol-Gel Technologies Ltd. (0.04%), Indaptus Therapeutics, Inc. (0.44%), Cocrystal Pharma, Inc. (0.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Minerva Neurosciences stock? Short selling NERV is an investing strategy that aims to generate trading profit from Minerva Neurosciences as its price is falling. NERV shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Minerva Neurosciences? A short squeeze for Minerva Neurosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NERV, which in turn drives the price of the stock up even further. How often is Minerva Neurosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NERV, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: TLPH Short Squeeze GLYC Short Squeeze FLGC Short Squeeze VBIV Short Squeeze VINC Short Squeeze GLTO Short Squeeze AYTU Short Squeeze SLGL Short Squeeze INDP Short Squeeze COCP Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NERV) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders